Relation Among Lipoprotein Subfractions and Carotid Atherosclerosis in Alaskan Eskimos (from the GOCADAN Study)

American Journal of Cardiology

Volumn 104, Issue 11, 2009, Pages 1516-1521

  Masulli, Maria ^a   Patti, Lidia ^a   Riccardi, Gabriele ^a   Vaccaro, Olga ^a   Annuzzi, Giovanni ^a   Ebbesson, Sven O E ^b   Fabsitz, Richard R ^c   Howard, Wm James ^d   Otvos, James D ^e   Roman, Mary J ^f   Wang, Hong ^g   Weissman, Neil J ^g   Howard, Barbara V ^g   Rivellese, Angela A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Norton Sound Health Corporation   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d WASHINGTON HOSPITAL CENTER   (Colombia)

^e LIPOSCIENCE INC   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g MEDSTAR RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESKIMO; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; INDEPENDENT VARIABLE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ALASKA; BIOLOGICAL MARKERS; BODY MASS INDEX; BODY WEIGHT; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INUITS; LIPOPROTEINS; LIPOPROTEINS, LDL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PARTICLE SIZE; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SAMPLE SIZE; TUNICA INTIMA; TUNICA MEDIA; WAIST-HIP RATIO;

EID: 71649105692     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.07.021     Document Type: Article

References (24)

1. Maynard J.E., Hammes L.M., and Kester F.E. Mortality due to heart disease among Alaskan natives 1955-65. Pub Health Rep 82 (1967) 714-720
2. Davidson M., Bulkow L.R., and Gellin B.G. Cardiac mortality in Alaska's indigenous and non-native residents. Int J Epidemiol 22 (1993) 62-71
3. Middaugh J.P. Cardiovascular deaths among Alaskan natives 1980-86. Am J Pub Health 80 (1990) 282-285
4. Newman W.P., Middaugh J.P., Propst M.T., and Rogers D.R. Atherosclerosis in Alaska natives and non-natives. Lancet 341 (1993) 1056-1057
5. Cutchins A., Roman M.J., Devereux R.B., Ebbesson S.O., Umans J.G., Zhu J., Weissman N.J., and Howard B.V. Prevalence and correlates of subclinical atherosclerosis in Alaska Eskimos: the GOCADAN study. Stroke 39 (2008) 3079-3082
6. Kaufman D.J., Roman M.J., Devereux R.B., Fabsitz R.R., MacCluer J.W., Dyke B., Ebbesson S.O., Wenger C.R., Romanesko T., Comuzzie A.G., and Howard B.V. Prevalence of smoking and its relationship with carotid atherosclerosis in Alaskan Eskimos of the Norton Sound region: the GOCADAN study. Nicotine Tob Res 10 (2008) 483-491
7. Howard B.V., Best L., Comuzzie A., Ebbesson S.O., Epstein S.E., Fabsitz R.R., Howard W.J., Silverman A., Wang H., Zhu J., and Umans J. C-reactive protein, insulin resistance, and metabolic syndrome in a population with a high burden of subclinical infection: insights from the GOCADAN study. Diabetes Care 12 (2008) 2312-2314
8. Rivellese A.A., Patti L., Kaufman D., Zhu J., Annuzzi G., Vaccaro O., Ebbesson S.O., Howard W.J., Riccardi G., and Howard B.V. Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: the GOCADAN study. Atherosclerosis 200 (2008) 350-358
9. Howard B.V., Devereux R.B., Cole S.A., Davidson M., Dyke B., Ebbesson S.O., Epstein S.E., Robinson D.R., Jarvis B., Kaufman D.J., Laston S., MacCluer J.W., Okin P.M., Roman M.J., Romenesko T., Ruotolo G., Swenson M., Wenger C.R., Williams-Blangero S., Zhu J., Saccheus C., Fabsitz R.R., and Robbins D.C. A genetic and epidemiologic study of cardiovascular disease in Alaska natives (GOCADAN): design and methods. Int J Circumpolar Health 64 (2005) 206-221
10. Ebbesson S.O., Laston S., Wenger C.R., Dyke B., Romenesko T., Swenson M., Fabsitz R.R., MacCluer J.W., Devereux R., Roman M., Robbins D., and Howard B.V. Recruitment and community interactions in the GOCADAN study. Int J Circumpolar Health 65 (2006) 55-64
11. The Expert Committee on the DiagnosisClassification of Diabetes mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1977) 1183-1197
12. Allain C.C., Poon L.S., Chan C.S., Richmond W., and Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
13. Spayd R.W., Bruschi B., Burdick B.A., Dappen G.M., Eikenberry J.N., Esders T.W., Figueras J., Goodhue C.T., LaRossa D.D., Nelson R.W., Rand R.N., and Wu T.W. Multilayer film elements for clinical analysis: applications to representative chemical determinations. Clin Chem 24 (1978) 1343-1350
14. Friedewald W.T., Levy R.I., and Fredrikson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
15. In: Burtis C.A., and Ashwood E.R. (Eds). Tietz Textbook of Clinical Chemistry. 2nd edn. (1994), WB Saunders, Philadelphia 943-944
16. Jeyarajah E.J., Cromwell W.C., and Otvos J.D. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 26 (2006) 847-870
17. Mora S., Szklo M., Otvos J.D., Greenland P., Psaty B.M., Goff Jr. D.C., O'Leary D.H., Saad M.F., Tsai M.Y., and Sharrett A.R. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 192 (2007) 211-217
18. Festa A., Williams K., Hanley A.J., Otvos J.D., Goff D.C., Wagenknecht L.E., and Haffner S.M. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation 111 (2005) 3465-3472
19. Devereux R.B., and Roman M.J. Evaluation of cardiac and vascular structure by echocardiography and other noninvasive techniques. In: Laragh J.H., and Brenner B.M. (Eds). Hypertension: Pathophysiology, Diagnosis, Management. 2nd ed. (1995), Raven Press, New York 1969-1985
20. Hulthe J., Wiklund O., Bondjers G., and Wikstrand J. LDL particle size in relation to intima-media thickness and plaque occurrence in the carotid and femoral arteries in patients with hypercholesterolaemia. J Intern Med 248 (2000) 42-52
21. Tzou W.S., Douglas P.S., Srinivasan S.R., Chen W., Berenson G., and Stein J.H. Advanced lipoprotein testing does not improve identification of subclinical atherosclerosis in young adults: the Bogalusa Heart Study. Ann Intern Med 142 (2005) 742-750
22. Liu M.L., Ylitalo K., Nuotio I., Salonen R., Salonen J.T., and Taskinen M.R. Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility of low-density lipoprotein to oxidation in asymptomatic members of familial combined hyperlipidemia families. Stroke 33 (2002) 1255-1260
23. Roche H.M., and Gibney M.J. The impact of postprandial lipemia in accelerating atherothrombosis. J Cardiovasc Risk 7 (2000) 317-324
24. Gianturco S.H., and Bradley W.A. Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: cellular aspects. Clin Cardiol 22 Suppl (1999) II7-II14